iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionClarity Wealth Advisors, LLC
Latest Disclosed Ownership4,831 shares
Latest Disclosed Value $ 815,790
Clarity Wealth Advisors, LLC reports 7.29% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 24, 2026 - Clarity Wealth Advisors, LLC filed a 13F-HR form disclosing ownership of 4,831 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $815,790 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 5,211 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -7.29% during the quarter. The current value of the position is $633,103 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,831 -380 -7.29 816 -7.28 0.1677
2026-01-23 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,211 -657 -11.20 880 3.78 0.1794
2025-10-24 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,868 -2,602 -30.72 847 -20.92 0.1867
2025-08-07 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,470 -2,019 -19.25 1,072 -20.13 0.2644
2025-04-30 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,489 -2,031 -16.22 1,342 -18.97 0.3721
2025-01-28 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,520 -1,309 -9.47 1,655 -17.78 0.4513
2024-10-18 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,829 -2,771 -16.69 2,014 -11.63 0.5852
2024-07-18 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,600 -5,146 -23.66 2,279 -23.63 0.7369
2024-04-18 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 21,746 -1,991 -8.39 2,984 -7.48 1.0090
2024-01-10 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 23,737 -5,885 -19.87 3,225 -10.99 1.2188
2023-11-07 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 29,622 185 0.63 3,622 -3.08 1.6433
2023-07-28 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 29,437 390 1.34 3,737 -0.37 1.6781
2023-05-10 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 29,047 268 0.93 3,752 -0.71 1.9123
2023-02-06 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 28,779 -154 -0.53 3,778 11.64 2.1766
2022-11-01 2022-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ISHARES BIOTECH 464287556 28,933 527 1.86 3,384 1.29 2.0387
2022-07-19 2022-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ISHARES BIOTECH 464287556 28,406 880 3.20 3,341 -6.83 1.9109
2022-05-02 2022-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ISHARES BIOTECH 464287556 27,526 773 2.89 3,586 -12.17 1.7029
2022-01-25 2021-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ISHARES BIOTECH 464287556 26,753 1,290 5.07 4,083 -0.80 1.8971
2021-10-20 2021-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ISHARES BIOTECH 464287556 25,463 749 3.03 4,116 1.78 2.0268
2021-08-12 2021-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ISHARES BIOTECH 464287556 24,714 1,201 5.11 4,044 14.24 2.0995
2021-04-28 2021-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY NASDAQ BIOTECH 464287556 23,513 903 3.99 3,540 3.36 2.0182
2021-02-04 2020-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY NASDAQ BIOTECH 464287556 22,610 470 2.12 3,425 14.28 2.0761
2020-10-13 2020-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY NASDAQ BIOTECH 464287556 22,140 437 2.01 2,997 1.05 2.1496
2020-08-04 2020-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY NASDAQ BIOTECH 464287556 21,703 1,344 6.60 2,966 35.25 2.3398
2020-04-29 2020-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY NASDAQ BIOTECH 464287556 20,359 673 3.42 2,193 -7.55 2.2819
2020-02-10 2019-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY NASDAQ BIOTECH 464287556 19,686 19,686 2,372 1.9947
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.